Pcn38 - Nivolumab Is Predicted to Have Improved Clinical Outcomes Over Best Supportive Care in a Western Population of Pre-Treated Gastric Cancer Patients; An Indirect Treatment Comparison Analysis

Value in Health - United Kingdom
doi 10.1016/j.jval.2018.09.120
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Elsevier BV

Related search

Looking for the Best Immune-Checkpoint Inhibitor in Pre-Treated NSCLC Patients: An Indirect Comparison Between Nivolumab, Pembrolizumab and Atezolizumab

International Journal of Cancer
Cancer ResearchOncology
2017English

Pcn17 - Indirect Treatment Comparisons of Nivolumab Versus Regorafenib, Cabozantinib and Best Supportive Care After Treatment With Sorafenib for Hepatocellular Carcinoma

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2018English

Nivolumab in Heavily Pretreated Metastatic Gastric Cancer Patients: Real-Life Data From a Western Population

OncoTargets and Therapy
OncologyPharmacology
2020English

Comparison of Pre-Treatment Clinical Characteristics and Post-Treatment Outcomes of Patients Treated With Clozapine and Long Acting Antipsychotics

Neuropsychiatry
PsychiatryMental HealthNeurology
2017English

Axitinib, Cabozantinib, Everolimus, Nivolumab, Sunitinib and Best Supportive Care in Previously Treated Renal Cell Carcinoma: A Systematic Review and Economic Evaluation

Health Technology Assessment
MedicineHealth Policy
2018English

Indirect Treatment Comparison of Cabazitaxel for Patients With Metastatic Castration-Resistant Prostate Cancer Who Have Been Previously Treated With a Docetaxel-Containing Regimen

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2016English

Association of Thymidylate Synthase Expression and Clinical Outcomes of Gastric Cancer Patients Treated With Fluoropyrimidine-Based Chemotherapy: A Meta-Analysis

OncoTargets and Therapy
OncologyPharmacology
2016English

Pnd58 - Cost-Effectiveness Analysis of Treatment With Abobotulinumtoxina Compared to Best Supportive Care in Patients With Upper Limb Spasticity in Sweden

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2018English

Efficacy of Nivolumab in Pre-Treated Non-Small-Cell Lung Cancer Patients Harbouring KRAS Mutations

British Journal of Cancer
Cancer ResearchOncology
2018English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2025 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy